Clinical trial
Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell…
NCT00003311 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003311 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma |
| Official title | Phase II CCOP Trial of High Dose Methotrexate/ARA-C and HCVAD for Newly Diagnosed Nodular and Diffuse Mantle Cell Lymphoma and Their Blastic Variants |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, cyclophosphamide, cytarabine, dexamethasone, doxorubicin hydrochloride, methotrexate, vincristine sulfate |
| Enrollment | 19 |
| Start date | May 20, 1998 |
| Primary completion | Apr 18, 2007 |
| Completion | Apr 18, 2007 |
| First posted | Apr 25, 2003 |
| Last update posted | Nov 14, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: